Adjuvant therapy with high-dose interferon α2b in patients with high-risk stage IIB/III melanoma
Year: 2007
Type: article
DOI: 10.1038/ncponc1004
Institutions: UPMC Hillman Cancer Center, University of Pittsburgh
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2038026390
